| Legislation/Issues | Synopsis | Resources | New This Week/Upcoming Dates |
|---|---|---|---|
| SB 186 - Maryland AIDS Drug Assistance Program Fund | Repealing provisions of law regarding funds and rebates related to the Maryland AIDS Drug Assistance Program; establishing the Maryland AIDS Drug Assistance Program Fund to support the administration, operation, and activities of the Maryland AIDS Drug Assistance Program; requiring interest earnings of the Fund to be credited to the Fund; and requiring the Maryland Department of Health to deposit certain rebates into a certain account and to use the account to fund State-identified priorities for HIV prevention, surveillance, and care services. | SB 186 | Approved by the Governor - Chapter 222 (4/21) SB 186: Hearing 1/20 at 1:00 p.m.@Education, Health, and Environmental Affairs SB 186: Hearing 3/23 at 1:30 p.m.@Health and Government Operations |
| SB 331 (HB 245) - Program for Preventing HIV Infection for Rape Victims - Alterations and Repeal of Sunset | Repealing the termination date of the Pilot Program for Preventing HIV Infection for Rape Victims; repealing the limit on the total annual amount physicians, qualified health care providers, and hospitals are entitled to be paid for providing certain treatment or follow-up care; and altering the requirement that the Governor's Office of Crime Prevention, Youth, and Victim Services report to the Governor and General Assembly on the operation and results of the program. | SB 331 HB 245 | Approved by the Governor - Chapter 144 (4/21) Vetoed by the Governor (Duplicative) (5/27) SB 331: Hearing 2/08 at 1:00 p.m.@Judicial Proceedings SB 331: Hearing 3/30 at 1:30 p.m. (Health and Government Operations)@Health and Government Operations HB 245: Hearing 2/09 at 1:30 p.m. (Health and Government Operations)@Health and Government Operations |
| SB 355 - HIV Prevention Drugs - Prescribing and Dispensing by Pharmacists and Insurance Requirements | Authorizing pharmacists to prescribe and dispense preexposure prophylaxis and postexposure prophylaxis for HIV prevention to patients under certain circumstances; requiring the Maryland Medical Assistance Program to provide drugs that are approved by the United States Food and Drug Administration for HIV prevention; prohibiting managed care organizations, certain insurers, nonprofit health service plans, and health maintenance organizations from requiring prior authorization for certain drugs for HIV prevention; etc. | SB 355 | Hearing 3/24 at 1:30 p.m. (3/18) SB 355: Hearing 3/24 at 1:30 p.m.@Health and Government Operations SB 355: Hearing 2/10 at 1:00 p.m. (Education, Health, and Environmental Affairs)@Education, Health, and Environmental Affairs |
| SB 547 - Public Health - Prohibition on Transfer of Human Immunodeficiency Virus - Repeal | Repealing the prohibition on an individual from knowingly transferring or attempting to transfer the human immunodeficiency virus to another individual. | SB 547 | Withdrawn by Sponsor (2/28) |
| SB 787 (HB 970) - Managed Care Organizations and Health Insurance Carriers - Prior Authorization for HIV Postexposure Prophylaxis for Victims of Sexual Offenses - Prohibition | Prohibiting managed care organizations and certain insurers, nonprofit health service plans, and health maintenance organizations from applying a prior authorization requirement for prescription drugs used as postexposure prophylaxis for the prevention of HIV if the drug is prescribed to a victim of an alleged rape or sexual offense. | SB 787 HB 970 | Hearing 2/23 at 1:00 p.m. (2/8) Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 684 (5/29) SB 787: Hearing 2/23 at 1:00 p.m.@Finance HB 970: Hearing 2/17 at 1:30 p.m.@Health and Government Operations |